[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:cardiorenal-syndrome":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Cardiorenal Syndrome",3,[7,14,20],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT05677100","Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure",[],"RECRUITING","2026-08-26T02:19:02.550788Z","2026-07-19T19:36:05.123903Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":18,"content_modified":19},"NCT03836482","Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD",[],"2026-08-26T02:16:27.227548Z","2026-05-05T02:43:26.951562Z",{"nct_id":21,"title":22,"phases":23,"status":11,"updated_at":25,"content_modified":26},"NCT07273838","Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome",[24],"Phase 2","2026-08-26T02:17:06.985283Z","2026-05-05T02:43:27.175144Z",[],[]]